SAS Enterprise Guide 6.1: baseline characteristics presentation
- Authors: Bunenkov N.S.1, Komok V.V.1, Grudinin N.V.2, Bobylkov V.A.1, Bunenkova G.F.3, Grinenko O.A.1, Nemkov A.S.1
-
Affiliations:
- Pavlov First Saint Petersburg State Medical University
- Shumakov National Medical Research Center of Transplantology and Artificial Organs
- S.M. Kirov Military Medical Academy
- Issue: Vol 21, No 1 (2021)
- Pages: 59-64
- Section: Original research
- URL: https://journals.eco-vector.com/MAJ/article/view/64682
- DOI: https://doi.org/10.17816/MAJ64682
- ID: 64682
Cite item
Abstract
Objective: to develop algorithm of presentation of baseline characteristics of patients which enrolled in prospective non-randomized clinical trial AMIRI – CABG (ClinicalTrials.gov Identifier: NCT03050489).
Materials and methods. Data collection was performed according to prospective non-randomized clinical trial AMIRI — CABG in Pavlov First St. Petersburg State Medical University, Saint Petersburg, Russia between 2016-2019 years with 336 patients. Patients were allocated into three groups of treatment. There is database with clinical, laboratory and instrumental data. Comparison for nominal data (gender and incidence of myocardial infarction and stroke) were calculated with SAS Enterprise Guide 6.1 software with Chi-squared test and exact Fisher test. Baseline characteristics were presented in table.
Results. There was developed algorithm of baseline characteristics presentation in APA-table.
Conclusion. There was developed algorithm of baseline characteristics presentation SAS Enterprise Guide 6.1 could be useful for manuscript preparing for Russian and foreign journal.
Full Text
About the authors
Nikolay S. Bunenkov
Pavlov First Saint Petersburg State Medical University
Author for correspondence.
Email: bunenkov2006@gmail.com
ORCID iD: 0000-0003-4331-028X
PhD student, Department of Faculty Surgery
Russian Federation, Saint PetersburgVladimir V. Komok
Pavlov First Saint Petersburg State Medical University
Email: vladimir_komok@mail.ru
ORCID iD: 0000-0002-3834-7566
SPIN-code: 3572-5180
MD, PhD (Medicine), Cardiac Surgeon, Department of Cardiac Surgery No. 2
Russian Federation, Saint PetersburgNikita V. Grudinin
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Email: nikita.grudinin@mail.ru
ORCID iD: 0000-0003-1100-9513
Cardiac Surgeon
Russian Federation, MoscowVasiliy A. Bobylkov
Pavlov First Saint Petersburg State Medical University
Email: basilbob@yandex.ru
Senior Laboratory Assistant, Department of Surgery Faculty
Russian Federation, Saint PetersburgGulnara F. Bunenkova
S.M. Kirov Military Medical Academy
Email: gulnara533@gmail.com
Teaching Physician, 2nd Department of Therapy
Russian Federation, Saint PetersburgOleg A. Grinenko
Pavlov First Saint Petersburg State Medical University
Email: klinika@spb-gmu.ru
MD, PhD, DSc (Medicine), Vice-rector
Russian Federation, St. PetersburgAleksandr S. Nemkov
Pavlov First Saint Petersburg State Medical University
Email: nemk_as@mail.ru
ORCID iD: 0000-0002-5152-0001
SPIN-code: 2853-4634
MD, PhD, DSc (Medicine), Professor, Cardiac Surgeon, Department of Cardiac Surgery No.2
Russian Federation, Saint PetersburgReferences
- Gu H-Q, Li D-J, Liu C, Rao Z-Z. %ggBaseline: a SAS macro for analyzing and reporting baseline characteristics automatically in medical research. Annals of Translational Medicine. 2018;6(16):326–326. doi: 10.21037/atm.2018.08.13
- Bunenkov NS, Bunenkova GF, Komok VV, et al. SAS enterprise guide 6.1 for physicians: multiple comparisons. Medical Academic Journal. 2019;19(4):33–40. (In Russ.). doi: 10.17816/MAJ17736
- Bunenkov NS, Bunenkova GF, Komok VV, et al. SAS enterprise guide 6.1: independent groups comparison for nominal data. Medical Academic Journal. 2020;20(3):89–98. (In Russ.). doi: 10.17816/MAJ34127
- Bunenkov NS, Bunenkova GF, Beliy SA, et al. SAS enterprise guide 6.1 for physicians: getting started. Medical Academic Journal. 2019;19(3):27–36. (In Russ.). doi: 10.17816/maj19327-36
- Vlasova II, Sokolov AV, Kostevich VA, et al. Myeloperoxidase-induced oxidation of albumin and ceruloplasmin: role of tyrosines. Biochemistry (Moscow). 2019;84(6):652–662. doi: 10.1134/S0320972519060095
- Grigorieva DV, Gorudko IV, Kostevich VA, et al. Myeloperoxidase activity in blood plasma as a criterion of therapy for patients with cardiovascular disease. Biomeditsinskaya khimiya. 2016;62(3):318–324. (In Russ.). doi: 10.18097/PBMC20166203318
- Panasenko OM, Mikhalchik EV, Sokolov AV, et al. The effects of antioxidants and hypohalous acid scavengers on neutrophil activation by hypochlorous acid-modified low-density lipoproteins. Biophysics. 2016;61(3):420–428.
- Sokolov AV, Kostevich VA, Gorbunov NP, et al. A link between active myeloperoxidase and chlorinated ceruloplasmin in blood plasma of patients with cardiovascular diseases. Medical Immunology (Russia). 2018;20(5):699–710. (In Russ.). doi: 10.15789/1563-0625-2018-5-699-710